Blog – Katalyst Wealth

[Sep’26] New Insider Bets stock recommendation dropping tonight

September 21, 2026

We’re releasing a new stock recommendation tonight under Insider Bets subscription. The Setup: Why this stock caught our attention – Promoter warrant conversion at a premium to CMP + capacity-led earnings inflection + reasonable valuations: Insider conviction, not just words: In FY24, the promoter group was allotted around 1 crore convertible warrants. They’ve since converted every single one – committing over ₹100 crore of personal capital – even as the stock now trades below that price. Promoters don’t usually pay…

[Stock idea]: Kiri Industries – A ₹20,000-25,000 crore guidance number, quietly dropped mid-call

September 15, 2026

Kiri Industries just received USD 689 million after an 11-year legal battle over its DyStar investment finally concluded. Consolidated PAT for the quarter came in at ₹270 crore — a number that looks spectacular until you see where it’s actually coming from. On the earnings call, a shareholder directly asked management why, after a decade of waiting, there’s still no dividend. The answer, and what the numbers underneath the headline actually show, are both worth reading before treating this quarter…

[Stock idea]: Aeroflex Enterprises – 169 startup bets, one ₹227 crore exit — how Aeroflex actually makes money

September 10, 2026

Aeroflex Enterprises doesn’t look like a typical listed manufacturer once you look past the P&L — it’s structured more like a holding company that incubates businesses, scales them, and exits. This quarter gives a clean example of the model working: a business bought for a stake in 2024 was sold to a global Fortune 500 buyer for ₹227 crore in April 2026, at roughly 3x the investment. Here’s how the structure works, and what to watch for once you look…

[Stock idea]: Krsnaa Diagnostics – This diagnostics company prices 90% below the market. How?

September 8, 2026

Krsnaa Diagnostics just posted 22% revenue growth. Its stock-friendly narrative talks about “purpose” and “Bharat Ka Bharosemand Diagnostics.” Here’s what the transcript and presentation actually show, and the questions we’d still want answered before treating this quarter as a green light, but before that: Spread the Word: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you spreading the word about Katalyst Wealth. Latest Stock recommendations under Alpha, Alpha +, and Insider Bets…